Search Results 551-560 of 13947 for Moderate acute malnutrition

  1. Tuberculosis - Symptoms and causes - Mayo Clinic

    Risk of active TB disease · HIV/AIDS. · Diabetes. · Severe kidney disease. · Cancers of the head, neck and blood. · Malnutrition or low body weight. · Cancer ...

  2. Rem-422, An MYB MRNA Degrader, In Patients With Relapsed/Refractory AML Or Higher-Risk MDS - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of REM-422 in patients with relapsed/refractory acute myeloid leukemia or higher-risk ...

  3. Crohn's Disease Treatment

    Symptoms may develop gradually or appear suddenly, and they can range from mild to severe. You may have periods when symptoms improve or disappear ...

  4. Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia - Mayo Clinic

    This phase III trial is studying combination chemotherapy to see how well it works in treating young patients with newly diagnosed acute promyelocytic leukemia.

  5. Crohn’s Disease Treatment - Mayo Clinic Healthcare

    Symptoms may develop gradually or appear suddenly, and they can range from mild to severe. You may have periods when symptoms improve or disappear ...

  6. A Study Of The Use Of Preoperative Antibiotics Given Preventively Prior To Kidney Stone Surgery To Patients At Moderate Risk Of Infection - Mayo Clinic

    A Study Of The Use Of Preoperative Antibiotics Given Preventively Prior To Kidney Stone Surgery To Patients At Moderate Risk Of Infection · Share · Facebook ...

  7. A Study Of Short-term Survival In Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% - Mayo Clinic

    The purpose of this study is to evaluate the effects of plasma exchange using human serum albumin 5% (PE-A 5%) in acute-on-chronic liver failure (ACLF) subjects ...

  8. A Safety Study Of SYNT001 In Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA) - Mayo Clinic

    This study is being conducted to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and effects on warm autoimmune ...

  9. A Phase 1-2 Dose-Escalation And Cohort-Expansion Study Of Oral EFT508 In Subjects With Hematological Malignancies - Mayo Clinic

    All acute toxic effects of any prior antitumor therapy resolved to Grade ≤1 before the start of study therapy (with the exception of alopecia [Grade 1 or 2 ...

  10. Cortical Excitability and Inhibition in MDD - Mayo Clinic

    Group 2: (50 subjects): Subjects with moderate to severe MDD who have not yet initiated treatment with an SSRI. Group 3: (50 subjects): Subjects with ...